par Ignatiadis, Michail ;Mavroudis, Dimitris;Veslemes, Marinos;Boukovinas, John;Syrigos, Kostas;Agelidou, Maria;Agelidou, Athina;Gerogianni, Aleka;Pavlakou, Georgia;Tselepatiotis, Evaggelos;Nikolakopoulos, John;Georgoulias, Vassilis
Référence Clinical lung cancer, 7, 3, page (183-189)
Publication Publié, 2005-11
Référence Clinical lung cancer, 7, 3, page (183-189)
Publication Publié, 2005-11
Article révisé par les pairs
Résumé : | This trial was designed to compare the efficacy and toxicity of sequential versus alternating administration of cisplatin/etoposide and topotecan in patients with previously untreated extensive-stage small-cell lung cancer (SCLC). |